Melanie B. Thomas - Concepedia

Author

Melanie B. Thomas

The University of Texas MD Anderson Cancer Center

Also Known As

Barakat, Suzanne, D. Stewart, M B Thomas, M Thomas, M. B. Thomas, M. Thomas, M.B. Thomas, MELANIE B. THOMAS, Melanie B Thomas, Melanie B. Thomas

136

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Medical University of South Carolina MUSC Hollings Cancer Center New Mexico Cancer Center UNM Comprehensive Cancer Center

About

Melanie B. Thomas is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.2K
2	Health Sciences	5	5	552
3	Engineering	2	2	127
4	Education	1	1	48
5	Nursing	1	1	20

Melanie B. Thomas

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma Edgar Ben‐Josef, Katherine A. Guthrie, Anthony B. El-Khoueiry, Journal of Clinical Oncology	2015	395
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Journal of Clinical Oncology GastroenterologyPathologyHepatic DisordersOncologyGastrointestinal Oncology	2010	393
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases Dario Ribero, Huamin Wang, Matteo Donadon, Cancer	2007	375
Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha, Journal of Clinical Oncology	2009	334
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma Melanie B. Thomas, Romil Chadha, Katrina Y. Glover, Cancer	2007	305
Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case?Control Study Yasser H. Shaib, Hashem B. El‐Serag, Ajay K. Nooka, The American Journal of Gastroenterology	2007	263
HER2/neu-directed therapy for biliary tract cancer Milind Javle, Chaitanya Churi, Hyunseon C. Kang, Journal of Hematology & Oncology	2015	220
Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States # Manal M. Hassan, Ahmed O. Kaseb, Donghui Li, Hepatology	2008	169
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors Carolyn D. Britten, Elizabeth Garrett‐Mayer, Steven Chin, Clinical Cancer Research	2017	159
Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma Joong‐Won Park, Richard S. Finn, Jun Suk Kim, Clinical Cancer Research	2011	142

Page 1